BlackRock Group’s PHARMACYCLICS INC PCYC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q2
Sell
-381,271
Closed -$97.6M 3002
2015
Q1
$97.6M Buy
381,271
+153,155
+67% +$29.6M 0.05% 410
2014
Q4
$27.9M Buy
228,116
+7,377
+3% +$943K 0.01% 724
2014
Q3
$25.9M Buy
220,739
+6,268
+3% +$714K 0.02% 725
2014
Q2
$19.2M Buy
214,471
+10,521
+5% +$987K 0.01% 803
2014
Q1
$20.4M Sell
203,950
-3,540
-2% -$460K 0.01% 768
2013
Q4
$21.9M Buy
207,490
+109,150
+111% +$13.2M 0.01% 744
2013
Q3
$13.6M Buy
98,340
+30,343
+45% +$3.37M 0.01% 863
2013
Q2
$5.4M Buy
+67,997
New +$5.56M ﹤0.01% 979

Other funds holding PCYC

BlackRock Group's PCYC Position: Q2 2015 in Review

BlackRock Group sold out of PHARMACYCLICS INC (PCYC) in Q2 2015, closing a stake of 381,271 shares — an estimated $97.6M sold.

BlackRock Group first reported a position in PCYC in Q2 2013 and held it in 8 quarters. The position peaked at $97.6M in Q1 2015. 1 fund tracked by Wall St. Rank holds PCYC as of Q2 2015.

  • BlackRock Group reported no remaining PHARMACYCLICS INC position as of Q2 2015 after selling out during the quarter.
  • BlackRock Group sold 381,271 PHARMACYCLICS INC shares in Q2 2015, an estimated $97.6M.
  • BlackRock Group first reported a position in PHARMACYCLICS INC in Q2 2013 and held it in 8 quarters.
  • BlackRock Group's PHARMACYCLICS INC position peaked at $97.6M in Q1 2015.
  • 1 fund tracked by Wall St. Rank held PHARMACYCLICS INC as of Q2 2015.

Based on BlackRock Group's 13F filing for Q2 2015, filed 7 Aug 2015.